NPI: 1982659264 · JACKSON, MS 39206 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 31,447 | $510K |
| 2019 | 27,721 | $470K |
| 2020 | 26,767 | $466K |
| 2021 | 19,150 | $309K |
| 2022 | 13,843 | $324K |
| 2023 | 9,071 | $509K |
| 2024 | 4,692 | $431K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 43,583 | 4,232 | $2.19M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,138 | 2,428 | $490K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,332 | 507 | $120K |
| 83970 | 3,063 | 2,179 | $83K | |
| J1756 | Injection, iron sucrose, 1 mg | 8,011 | 1,793 | $32K |
| A4657 | Syringe, with or without needle, each | 7,499 | 3,004 | $32K |
| 82728 | 1,924 | 1,642 | $18K | |
| 83550 | 1,811 | 1,581 | $12K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,438 | 2,122 | $9K |
| 83540 | 2,024 | 1,701 | $9K | |
| 82108 | 332 | 304 | $7K | |
| 85045 | 2,182 | 1,885 | $5K | |
| 85041 | 2,274 | 1,935 | $4K | |
| 85048 | 2,251 | 1,912 | $4K | |
| 82607 | 105 | 94 | $1K | |
| 82746 | 106 | 94 | $1K | |
| 90674 | 87 | 72 | $1K | |
| 90747 | 34 | 29 | $591.15 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 645 | 352 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 137 | 109 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 33 | 28 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 670 | 279 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 12 | 12 | $0.00 |